Fengjuan Lin

775 total citations
30 papers, 575 citations indexed

About

Fengjuan Lin is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fengjuan Lin has authored 30 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fengjuan Lin's work include Radiopharmaceutical Chemistry and Applications (6 papers), Extracellular vesicles in disease (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Fengjuan Lin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Extracellular vesicles in disease (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Fengjuan Lin collaborates with scholars based in China, United States and Australia. Fengjuan Lin's co-authors include Xiaoxiao Ge, Congqi Dai, Wenbo Tang, Zheng Wu, Gong Yang, Ziliang Wang, Zhouluo Ou, Jiao Meng, Changfu Huang and Jinjia Chang and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Fengjuan Lin

28 papers receiving 567 citations

Peers

Fengjuan Lin
Víctor Manuel Barberá Spain
Abu Shadat Mohammod Noman Bangladesh
Xu Shi China
Celine L. Hartman United States
Reshma Murali India
Shirin Hafezi United Arab Emirates
Guorong Hu China
Grażyna Kubiak-Tomaszewska Poland
Lechuang Chen China
Heng Zheng United States
Víctor Manuel Barberá Spain
Fengjuan Lin
Citations per year, relative to Fengjuan Lin Fengjuan Lin (= 1×) peers Víctor Manuel Barberá

Countries citing papers authored by Fengjuan Lin

Since Specialization
Citations

This map shows the geographic impact of Fengjuan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjuan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjuan Lin more than expected).

Fields of papers citing papers by Fengjuan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengjuan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjuan Lin. The network helps show where Fengjuan Lin may publish in the future.

Co-authorship network of co-authors of Fengjuan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fengjuan Lin. A scholar is included among the top collaborators of Fengjuan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengjuan Lin. Fengjuan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Fengjuan, et al.. (2025). Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases. Frontiers in Immunology. 15. 1479330–1479330. 3 indexed citations
2.
3.
Xue, Junli, Yan Zhang, Xudong Hu, et al.. (2024). Phase I/II safety and preliminary efficacy of PM1022, a bispecific antibody targeting PD-L1 and TIGIT, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e14694–e14694. 2 indexed citations
4.
Guo, Ye, Lihua Wu, Yong Li, et al.. (2024). First-in-human phase I/II safety and preliminary efficacy of PM1032, a bispecific antibody targeting CLDN18.2 and 4-1BB, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2662–2662. 3 indexed citations
5.
Lin, Fengjuan, Yuguo Liu, Li Gan, et al.. (2024). Macrophage exosomes mediate palmitic acid-induced metainflammation by transferring miR-3064-5p to target IκBα and activate NF-κB signaling. Journal of Advanced Research. 71. 501–519. 2 indexed citations
6.
Lin, Fengjuan, et al.. (2024). Phase 1 study of ZV0203, a first in class pertuzumab ADC, in patients with HER2 positive advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e15004–e15004. 2 indexed citations
7.
8.
Lin, Fengjuan, Yang Xia, Xiangqian Xiao, et al.. (2023). Coordinated modulation of long non-coding RNA ASBEL and curcumin co-delivery through multicomponent nanocomplexes for synchronous triple-negative breast cancer theranostics. Journal of Nanobiotechnology. 21(1). 397–397. 3 indexed citations
9.
Zheng, Zhongdaixi, Fengjuan Lin, Junbin Chen, et al.. (2023). Milk Exosomes from Gestational Diabetes Mellitus (GDM) and Healthy Parturient Exhibit Differential miRNAs Profiles and Distinct Regulatory Bioactivity on Hepatocyte Proliferation. Molecular Nutrition & Food Research. 67(16). e2300005–e2300005. 6 indexed citations
10.
Li, Qun, Ye Guo, Junli Xue, et al.. (2023). Safety and tolerability of HLX07 combined with chemotherapy in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15001–e15001. 1 indexed citations
11.
Yu, Minhao, Hao Wang, Wei Zhao, et al.. (2022). Targeting type Iγ phosphatidylinositol phosphate kinase overcomes oxaliplatin resistance in colorectal cancer. Theranostics. 12(9). 4386–4398. 14 indexed citations
12.
Ge, Xiaoxiao, Fengjuan Lin, Zheng Wu, et al.. (2022). Role of ROR2 in promoting gastric cancer metastasis by enhancing c-JUN-mediated MMP3 transcription. Annals of Translational Medicine. 10(20). 1117–1117. 4 indexed citations
13.
14.
Xu, Liang, Xiaoxiao Ge, Jin Li, et al.. (2022). Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors. Frontiers in Oncology. 12. 971594–971594. 5 indexed citations
15.
Zhao, Zhi, Changfu Huang, Ziyu Huang, et al.. (2021). Advancements in electrochemical biosensing for respiratory virus detection: A review. TrAC Trends in Analytical Chemistry. 139. 116253–116253. 96 indexed citations
16.
Han, Xu, Fengjuan Lin, Ziliang Wang, et al.. (2017). CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Letters. 412. 69–80. 86 indexed citations
17.
Lin, Fengjuan, Congqi Dai, Xiaoxiao Ge, et al.. (2017). Prognostic significance and functional implication of immune activating receptor NKG2D in gastric cancer. Biochemical and Biophysical Research Communications. 487(3). 619–624. 11 indexed citations
18.
Lin, Fengjuan, Wen Gao, Jiong Wu, et al.. (2013). COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness. Tumor Biology. 34(5). 2817–2826. 38 indexed citations
19.
Derfoul, Assia, et al.. (2003). Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells. Journal of Cellular Biochemistry. 89(4). 755–770. 24 indexed citations
20.
Lin, Fengjuan, et al.. (1997). Effects of cadmium on trophoblast calcium transport. Placenta. 18(4). 341–356. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Víctor Manuel Barberá Breakdown of academic impact, for papers by Abu Shadat Mohammod Noman Breakdown of academic impact, for papers by Xu Shi Breakdown of academic impact, for papers by Celine L. Hartman Breakdown of academic impact, for papers by Reshma Murali Breakdown of academic impact, for papers by Shirin Hafezi Breakdown of academic impact, for papers by Guorong Hu Breakdown of academic impact, for papers by Grażyna Kubiak-Tomaszewska Breakdown of academic impact, for papers by Lechuang Chen Breakdown of academic impact, for papers by Heng Zheng
Rankless by CCL
2026